Discover
ABCL
AbCellera Biologics Inc.
7.60
2 x 5.61
2 x 9.36
bid
ask
-
0.25
3.18%
2 @ 06:18 AM
7.40 -0.20 (2.63%)
| Ytd | 122.22% | |
| 1y | 117.77% |
7.26
day range
7.85
2.75
52 week range
8.42
| Open | 7.69 | Prev Close | 7.85 | Low | 7.26 | High | 7.85 | Mkt Cap | 2.32B |
| Vol | 7.97M | Avg Vol | 7.57M | EPS | -0.48 | P/E | N/A | Forward P/E | -10.56 |
| Beta | 1.20 | Short Ratio | 6.05 | Inst. Own | 42.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 5.27 | 200-d Avg | 4.36 | 1yr Est | 10.43 |
ABCL News
zacks.com
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
ABCELLERA BIOLG (ABCL) was a big mover last session on higher-than-average trading volume. The lates
benzinga.com
Jazz Pharmaceuticals Gains Oncology Firepower Through AbCellera Collaboration
Jazz Pharmaceuticals teams with AbCellera on cancer therapies as analysts maintain positive targets
benzinga.com
Jazz Pharma And AbCellera Announce Preclinical Research Collaboration, Option And License Agreement
The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in po